DEVON CARSON: Open Payments
NPI 1831521087 · MONONGAHELA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$652 in 28 payments from 7 companies in 2025. Trend: 2023 $895 · 2024 $1,689 · 2025 $652
Food & beverage: $652
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $271 |
| Novo Nordisk Inc | 4 | $140 |
| Novartis Pharmaceuticals Corporation | 3 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $62 |
| Travere Therapeutics, Inc. | 2 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
Products named: KRYSTEXXA, Ozempic, Kerendia, Vanrafia, Fabhalta, JARDIANCE, FARXIGA.
Industry payments across PA — which companies pay providers there.
